Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Kalinke

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Trends in Neurosciences|December 15, 2021
Beneficial and detrimental functions of microglia during viral encephalitisInken Waltl, Ulrich Kalinke
The EMBO Journal|April 26, 2022
Toll-like receptors matter: plasmacytoid dendritic cells in COVID-19Jennifer Becker, Ulrich Kalinke
Trends in Molecular Medicine|July 2, 2010
New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNSMarco Prinz, Ulrich Kalinke
Immunology and Cell Biology|March 21, 2012
Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNSUlrich Kalinke, Marco Prinz
Immunity|May 17, 2008
CD28 superagonists: what makes the difference in humans?Burkhart Schraven, Ulrich Kalinke
Nature Biotechnology|September 10, 2008
Toward biosimilar monoclonal antibodiesChristian K Schneider, Ulrich Kalinke
Hepatology International|October 3, 2025
B-cell subset heterogeneity in the liver during chronic hepatitis BAbdus Salam, Ulrich Kalinke, Matthias Bruhn
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2017
cGAMP Quantification in Virus-Infected Human Monocyte-Derived Cells by HPLC-Coupled Tandem Mass SpectrometryJennifer Paijo, Volkhard Kaever, Ulrich Kalinke
Nature Reviews. Immunology|March 21, 2015
Regulation of antiviral T cell responses by type I interferonsJosh Crouse, Ulrich Kalinke, Annette Oxenius
Critical Reviews in Immunology|November 4, 2019
RNA-Based Adjuvants: Immunoenhancing Effect on Antiviral Vaccines and Regulatory ConsiderationsAnnett Ziegler, Thomas Hinz, Ulrich Kalinke
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Trends in Neurosciences|December 15, 2021
Beneficial and detrimental functions of microglia during viral encephalitisInken Waltl, Ulrich Kalinke
The EMBO Journal|April 26, 2022
Toll-like receptors matter: plasmacytoid dendritic cells in COVID-19Jennifer Becker, Ulrich Kalinke
Trends in Molecular Medicine|July 2, 2010
New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNSMarco Prinz, Ulrich Kalinke
Immunology and Cell Biology|March 21, 2012
Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNSUlrich Kalinke, Marco Prinz
Immunity|May 17, 2008
CD28 superagonists: what makes the difference in humans?Burkhart Schraven, Ulrich Kalinke
Nature Biotechnology|September 10, 2008
Toward biosimilar monoclonal antibodiesChristian K Schneider, Ulrich Kalinke
Hepatology International|October 3, 2025
B-cell subset heterogeneity in the liver during chronic hepatitis BAbdus Salam, Ulrich Kalinke, Matthias Bruhn
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2017
cGAMP Quantification in Virus-Infected Human Monocyte-Derived Cells by HPLC-Coupled Tandem Mass SpectrometryJennifer Paijo, Volkhard Kaever, Ulrich Kalinke
Nature Reviews. Immunology|March 21, 2015
Regulation of antiviral T cell responses by type I interferonsJosh Crouse, Ulrich Kalinke, Annette Oxenius
Critical Reviews in Immunology|November 4, 2019
RNA-Based Adjuvants: Immunoenhancing Effect on Antiviral Vaccines and Regulatory ConsiderationsAnnett Ziegler, Thomas Hinz, Ulrich Kalinke
Pageof 25